BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16714009)

  • 1. Real-time telomeric repeat amplification protocol using the duplex scorpion and two reverse primers system: the high sensitive and accurate method for quantification of telomerase activity.
    Huang YP; Liu ZS; Tang H; Liu M; Li X
    Clin Chim Acta; 2006 Oct; 372(1-2):112-9. PubMed ID: 16714009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray TRAP--a high-throughput assay to quantitate telomerase activity.
    Heller-Uszynska K; Kilian A
    Biochem Biophys Res Commun; 2004 Oct; 323(2):465-72. PubMed ID: 15369774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of human telomerase activity by telomerase TRAP-ELISA assay].
    Wei L; Guo Y; Yan Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):264-6. PubMed ID: 10920979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
    Liu Y; Wu BQ; Zhong HH; Xu ML; Fang WG
    Pathol Int; 2010 May; 60(5):386-94. PubMed ID: 20518889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol.
    Herbert BS; Hochreiter AE; Wright WE; Shay JW
    Nat Protoc; 2006; 1(3):1583-90. PubMed ID: 17406450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of telomerase activity in high concentration of cell lysates using primer-modified gold nanoparticles.
    Xiao Y; Dane KY; Uzawa T; Csordas A; Qian J; Soh HT; Daugherty PS; Lagally ET; Heeger AJ; Plaxco KW
    J Am Chem Soc; 2010 Nov; 132(43):15299-307. PubMed ID: 20932008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput analysis of telomerase by capillary electrophoresis.
    Atha DH; Miller K; Sanow AD; Xu J; Hess JL; Wu OC; Wang W; Srivastava S; Highsmith WE
    Electrophoresis; 2003 Jan; 24(1-2):109-14. PubMed ID: 12652580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients.
    Shim WY; Park KH; Jeung HC; Kim YT; Kim TS; Hyung WJ; An SH; Yang SH; Noh SH; Chung HC; Rha SY
    Int J Mol Med; 2005 Nov; 16(5):857-63. PubMed ID: 16211255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and quantification of telomerase enzyme activity.
    Maritz MF; Richards LA; Mackenzie KL
    Methods Mol Biol; 2013; 965():215-31. PubMed ID: 23296661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
    Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
    Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of telomerase activity by the TRAP assay and its variants and alternatives.
    Fajkus J
    Clin Chim Acta; 2006 Sep; 371(1-2):25-31. PubMed ID: 16616059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity.
    Hou M; Xu D; Björkholm M; Gruber A
    Clin Chem; 2001 Mar; 47(3):519-24. PubMed ID: 11238306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
    Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
    Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of telomerase activity and its clinical application].
    Ohyashiki K; Ohyashiki JH; Yahata N; Toyama K
    Rinsho Byori; 1997 Dec; 45(12):1133-41. PubMed ID: 9437893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomeric repeat amplification protocol: measuring the activity of the telomerase.
    Xin H
    Methods Mol Biol; 2011; 735():107-11. PubMed ID: 21461815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
    Gomez D; Mergny JL; Riou JF
    Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
    Gao XD; Chen YR
    Asian J Androl; 2007 Sep; 9(5):697-704. PubMed ID: 17712489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.
    Reed J; Gunaratnam M; Beltran M; Reszka AP; Vilar R; Neidle S
    Anal Biochem; 2008 Sep; 380(1):99-105. PubMed ID: 18534183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.